HIF-1α is considered to be a potential prognostic marker of many cancers, including OSCC17, and HIF-1α overexpression has been correlated with tumor stage, lymph node metastasis, and poor survival in OSCC18. This evidence concerns the gene HIF1A and neoplasm.